Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Anavex Lf SC (NQ: AVXL)
2.910 USD  -0.120 (-3.96%)
Official Closing Price  /  Updated: 7:55 PM EST, Dec 5, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,691,500
Open 3.210
Bid (Size) 2.750 (5)
Ask (Size) 2.840 (4)
Prev. Close 3.030
Today's Range 2.710 - 3.450
52wk Range 1.250 - 4.090
Shares Outstanding 44,660,062
Dividend Yield N/A
Performance
YTD
+73.21%
+73.21%
1 Month
+7.38%
+7.38%
3 Month
+9.81%
+9.81%
6 Month
-2.35%
-2.35%
1 Year
+31.67%
+31.67%
Top News
More News
Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer's Disease (CTAD) 2019 Conference
from GlobeNewswire News Releases
Top Penny Stocks To Watch On Thursday
from Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
More News
Read More
Anavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX®2-73 (blarcamesine) for the Treatment of Rett Syndrome
from GlobeNewswire News Releases
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Rett Syndrome
from GlobeNewswire News Releases
Anavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Clinical Study in Early Alzheimer’s Disease
from GlobeNewswire News Releases
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73 for the Treatment of Alzheimer’s Disease
from GlobeNewswire News Releases
Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from the U.S. Rett Syndrome Phase 2 ANAVEX®2-73 Study
from GlobeNewswire News Releases
Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
from GlobeNewswire News Releases
Anavex Life Sciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference
from GlobeNewswire News Releases
Anavex Life Sciences Announces Preliminary Clinical Efficacy Data of its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patients with Rett Syndrome
from GlobeNewswire News Releases
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
category LCI , General , Movers , and 20 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.